Data Triumph at C
Authors:
- 1 April 2017
- journal article
- editorial
- Published by Elsevier in Cancer Cell
- Vol. 31 (4) , 467-469
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- Marcus Foundation (NCT02516670)
This publication has 9 references indexed in Scilit:
- O2⋅− and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological AscorbateCancer Cell, 2017
- High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of ChemotherapyScience Translational Medicine, 2014
- Vitamin C: A Concentration-Function Approach Yields Pharmacology and Therapeutic DiscoveriesAdvances in Nutrition, 2011
- Vitamin C: Intravenous Use by Complementary and Alternative Medicine Practitioners and Adverse EffectsPLOS ONE, 2010
- Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effectsFree Radical Biology and Medicine, 2009
- Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in miceProceedings of the National Academy of Sciences, 2008
- Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivoProceedings of the National Academy of Sciences, 2007
- Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissuesProceedings of the National Academy of Sciences, 2005
- Reevaluation of Ascorbate in Cancer Treatment: Emerging Evidence, Open Minds and SerendipityJournal of the American College of Nutrition, 2000